Geron (GERN) Exchange Rate Effect (2022 - 2026)
Geron's (GERN) quarterly Exchange Rate Effect came in at -$100000.0 in Q2 2026, down 3433.33% year-over-year from $3000.0 in Q2 2025, and down 177.78% quarter-over-quarter from -$36000.0 in Q1 2026.
Analysis
Geron (GERN) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Geron has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$100000.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 3433.33% year-over-year to -$100000.0; the TTM figure through Jun 2026 stood at -$70000.0 (down 275.0% YoY), while the FY2025 annual figure was $87000.0, up 825.0% from the prior year.
- Exchange Rate Effect came in at -$100000.0 for Q2 2026 at Geron, down from -$36000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $75000.0 in Q3 2025 to a low of -$100000.0 in Q2 2026.
- Average Exchange Rate Effect over 4 years is -$5454.5, with a median of -$9000.0 recorded in 2025.
- Year-over-year, Exchange Rate Effect soared 280.0% in 2025 and sank 3433.33% in 2026.
- Over 4 years, Exchange Rate Effect stood at $1000.0 in 2022, then tumbled by 3000.0% to -$29000.0 in 2024, then soared by 68.97% to -$9000.0 in 2025, then tumbled by 1011.11% to -$100000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$100000.0 in Q2 2026, -$36000.0 in Q1 2026, and -$9000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -100,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -100,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Mar 31, 2022 | 1,000.00 |